We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.61%
2 Industrials 3.56%
3 Consumer Discretionary 3.22%
4 Technology 3.15%
5 Healthcare 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPEL icon
2651
XPEL
XPEL
$1.37B
$2K ﹤0.01%
199
-937
-82% -$12.7K
XPRO icon
2652
Expro Ltd
XPRO
$2.11B
$2K ﹤0.01%
152
-156
-51% -$3.29K
ARQ icon
2653
Arq
ARQ
$101M
$2K ﹤0.01%
264
-2,328
-90% -$22.6K
TEN
2654
Tsakos Energy Navigation Ltd
TEN
$1.26B
$2K ﹤0.01%
+114
New +$1.75K
UCB
2655
United Community Banks
UCB
$4.42B
$2K ﹤0.01%
100
-6,071
-98% -$157K
TPC
2656
Tutor Perini Cor
TPC
$5.11B
$2K ﹤0.01%
284
-950
-77% -$10.2K
PMD
2657
DELISTED
Psychemedics Corporation
PMD
$2K ﹤0.01%
248
-174
-41% -$1.47K
EGIO
2658
DELISTED
Edgio, Inc. Common Stock
EGIO
$2K ﹤0.01%
11
+6
+120% +$1.19K
ALIM
2659
DELISTED
Alimera Sciences
ALIM
$2K ﹤0.01%
531
-2,216
-81% -$13.5K
BIMI
2660
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$2K ﹤0.01%
+14
New +$2.28K
TPHS
2661
DELISTED
Trinity Place Holdings Inc.com
TPHS
$2K ﹤0.01%
1,441
-958
-40% -$2.76K
FSD
2662
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$2K ﹤0.01%
169
-737
-81% -$10.7K
CATC
2663
DELISTED
CAMBRIDGE BANCORP
CATC
$2K ﹤0.01%
+48
New +$3.27K
ICD
2664
DELISTED
Independence Contract Drilling, Inc.
ICD
$2K ﹤0.01%
+1,328
New +$13.9K
MRNS
2665
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
+215
New +$1.86K
MDC
2666
DELISTED
M.D.C. Holdings, Inc.
MDC
$2K ﹤0.01%
91
-1,748
-95% -$61.2K
AYX
2667
DELISTED
Alteryx Inc
AYX
$2K ﹤0.01%
+25
New +$3.1K
SIEN
2668
DELISTED
Sientra, Inc.
SIEN
$2K ﹤0.01%
105
+5
+5% +$261
MRTX
2669
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2K ﹤0.01%
25
-615
-96% -$55.2K
PACW
2670
DELISTED
PacWest Bancorp
PACW
$2K ﹤0.01%
119
-428
-78% -$13.4K
ACER
2671
DELISTED
Acer Therapeutics Inc
ACER
$2K ﹤0.01%
1,226
+161
+15% +$590
DRTT
2672
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
$2K ﹤0.01%
2,000
+100
+5% +$229
NUVA
2673
DELISTED
NuVasive, Inc.
NUVA
$2K ﹤0.01%
42
-2,601
-98% -$174K
DMS
2674
DELISTED
Digital Media Solutions, Inc.
DMS
$2K ﹤0.01%
13
-57
-81% -$8.86K
SAL
2675
DELISTED
Salisbury Bancorp, Inc.
SAL
$2K ﹤0.01%
148
+120
+429% +$2.43K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.6% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.